KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Moderna (MRNA) over the last 10 years, with Q3 2025 value amounting to $2.8 billion.

  • Moderna's Total Liabilities fell 2763.16% to $2.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 billion, marking a year-over-year decrease of 2763.16%. This contributed to the annual value of $3.2 billion for FY2024, which is 2911.2% down from last year.
  • Moderna's Total Liabilities amounted to $2.8 billion in Q3 2025, which was down 2763.16% from $2.6 billion recorded in Q2 2025.
  • Over the past 5 years, Moderna's Total Liabilities peaked at $10.8 billion during Q3 2021, and registered a low of $2.6 billion during Q2 2025.
  • Moreover, its 5-year median value for Total Liabilities was $5.3 billion (2023), whereas its average is $6.1 billion.
  • In the last 5 years, Moderna's Total Liabilities surged by 197562.34% in 2021 and then tumbled by 5004.75% in 2023.
  • Moderna's Total Liabilities (Quarter) stood at $10.5 billion in 2021, then crashed by 36.0% to $6.7 billion in 2022, then tumbled by 32.12% to $4.6 billion in 2023, then dropped by 29.11% to $3.2 billion in 2024, then decreased by 13.45% to $2.8 billion in 2025.
  • Its Total Liabilities was $2.8 billion in Q3 2025, compared to $2.6 billion in Q2 2025 and $2.6 billion in Q1 2025.